CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.
| Image |  |
|---|---|
| Description | scientific article published on 29 January 2016 |
| Author/s |
author: Laurie Galvan Nathalie Cartier Anabelle Planques Jocelyne Caboche |
| Publication date | January 29, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |